Skip to content
Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines episode artwork

Mar 26, 2025

Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines

from Info Risk Today Podcast Hosted by InfoRiskToday.com

While recent draft guidance from the Food and Drug Administration on artificial intelligence-enabled medical devices is non-binding, the document signals that the agency is intensifying its regulatory scrutiny of these technologies, said Dr. Scott Schell of IT consulting firm Cognizant.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Reading the Tea Leaves in FDA's AI-Enabled Device Guidelines

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

When was this Info Risk Today Podcast episode published?

This episode was published on March 26, 2025.

Can I download this Info Risk Today Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.